As presented at ASCO, second-line bevacizumab (Avastin) as monotherapy has been associated with a 28% response rate and an overall survival edge for refractory glioblastoma. Also presented at…
Joseph Schoepf, M.D., Associate Professor of Radiology and Cardiology, Director of Computed Tomography Research, Medical University of South Carolina, discusses the advantages of using CTA. References and Resources…
Mary Wright, MD, Associate Professor & Director, Breast Center, Section of Breast Surgery, Department of Surgery, Tulane University School of Medicine, discusses Tulane’s Breast Cancer Center. References and…
Jacob G. Robison, MD, Professor, Vascular Surgery, Medical University of South Carolina, discusses drug-eluting stents. References and Resources Baker M, Uflacker R, Robison JG. Stent graft infection after…
A 50-week, placebo-controlled trial shows that combining infliximab and methotrexate provides no extra benefit in treating Crohn’s disease. References and Resources Feagan B. A randomized trial of methotrexate…
Francis G. Spinale, MD, PhD, Associate Professor, Department of Surgery, Medical University of South Carolina, discusses biomarkers in heart failure. References and Resources Spinale FG. Myocardial matrix remodeling…
Joseph Romagnuolo, M.D., FRCP, MSc, Associate Professor, Gastroenterology and Hepatology, Medical University of South Carolina, discusses ERCP. References and Resources Nguyen K, Sing JT Jr. Review of endoscopic…
Jacob G. Robison, MD, Professor, Vascular Surgery, Medical University of South Carolina, discusses differentials, diagnosis, and treatments of acute abdominal pain. References and Resources Borghi F, Giraudo G,…
A meta-analysis of observational studies showed that oral estrogen, but not transdermal estrogen, increased the risk of venous thromboembolism. References and Resources Canonico M, Plu-Bureau G, Lowe GD,…
Using a multivariate regression analysis, it has been shown that people with a common genetic mutation have up to twice the risk of lung cancer as do people…